Growth and Weight Gain in ELBW Infants Fed an Exclusively Human Milk Based Diet With Prolacta®
Sponsored by Medical University of Vienna
About this trial
Last updated 6 years ago
Study ID
Prolacta
Status
Completed
Type
Observational
Placebo
No
Accepting
1 to 8 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 7 years ago
What is this trial about?
Preterm infants are susceptible to postnatal growth restriction. Breast milk is the
recommended source of nutrition for preterm infants. As preterm infants have enhanced
nutritional requirements, multicomponent fortifiers are added to breast milk in order to
establish adequate growth.
Due to the various benefits of human milk feds to preterm infants, a human milk fortifier
based on donor milk (Prolact+6 H2MF® Prolacta, City of Industry, California) has been
developed. With this study, the investigators want to evaluate the effect of human milk
fortification on weight gain in extremely low birth weight infants (ELBW, <1000g birth
weight) in comparison to bovine fortification.
What are the participation requirements?
Inclusion Criteria
- Preterm infants with a birth weight <1000 g
Exclusion Criteria
- Congenital heart disease
- Major congenital birth defects
- Major inborn error of metabolism